Azidus Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 11-12-2024
- Paid Up Capital ₹ 2.50 M
as on 11-12-2024
- Company Age 28 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 28.04%
(FY 2022)
- Profit 67.81%
(FY 2022)
- Ebitda 49.67%
(FY 2022)
- Net Worth 12.70%
(FY 2022)
- Total Assets 5.53%
(FY 2022)
About Azidus Laboratories
The Corporate was formerly known as Omsoc Laboratories Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Geethalakshmi, Olaganathan Arjun, and Viswanathan Shanmugasundaram serve as directors at the Company.
- CIN/LLPIN
U24231TN1996PLC036136
- Company No.
036136
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Jul 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Azidus Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Olaganathan Arjun  | Managing Director | 14-Dec-2011 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Geethalakshmi | Director | 01-Aug-2022 | Current |
| Viswanathan Shanmugasundaram | Director | 01-Aug-2022 | Current |
Financial Performance of Azidus Laboratories.
Azidus Laboratories Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.04% increase. The company also saw a substantial improvement in profitability, with a 67.81% increase in profit. The company's net worth Soared by an impressive increase of 12.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Azidus Laboratories?
In 2022, Azidus Laboratories had a promoter holding of 99.60% and a public holding of 0.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Flaring Formulations Private LimitedActive 34 years 8 monthsViswanathan Shanmugasundaram is a mutual person
Atoz Pharmaceuticals Private LimitedActive 26 years 10 monthsViswanathan Shanmugasundaram is a mutual person
- Adroit Clinicals Private LimitedActive 9 years 4 months
Olaganathan Arjun and Viswanathan Shanmugasundaram are mutual person
- Baddi Print Packs Private LimitedActive 19 years 7 months
Viswanathan Shanmugasundaram is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Azidus Laboratories?
Azidus Laboratories has a workforce of 229 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Azidus Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Azidus Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
